Patent Yard Sign in
Expired Canadian patentCanada

Prostaglandin i2 analogue and pharmaceutical containing the same

CA 1280112 C · Owner: Mitsubishi Kasei Corporation · Inventors: Sodeoka, Mikiko; Hayasi, Yosio; Iseki, Katsuhiko

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

There are disclosed a prostaglandin I2 analogue represented by the formula:, wherein R1 represents a hydrogen atom an alkyl group, having 1 to 12 carbon atoms a cycloalkyl group, having 4 to 7 carbon atoms or a phenyl group A, represents a cyclohexyl group, 1-methyl-3-hexynyl group, 2-methyl-3-hexynyl group, 1-methylhexyl group 2-phenethyl group, 1,1-dimethylpentyl group 2-methylpentyl group, 1-cyclohexylethyl group or a 2-methylhexyl group, the double bond between the carbon atoms at 4- and 5-positiohs is E or Z or a mixture thereof, the asymmetric center in the substituent represented by A is R-configuration or S-configuration or a mixture thereof, and a pharmaceutical having circulation …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted February 12, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 12, 2008.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 31, 1986
GrantedFebruary 12, 1991
Term endedFebruary 12, 2008
Patent numberCA 1280112 C
Classification (IPC)C07C405/00 +2 more

Timeline

Timeline From CIPO dates

19871990199319961999200220052008Application filedJuly 31, 1986Patent grantedFeb 12, 1991Term endedFeb 12, 2008

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.